Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72 | 244 | 388 | 92 | 42 |
| TOTAL | $72 | $743 | $887 | $366 | $316 |
| Non-Current Assets | |||||
| Intangibles | 47 | 19 | 19 | 19 | 10 |
| TOTAL | $47 | $19 | $19 | $19 | $10 |
| Total Assets | $119 | $762 | $906 | $385 | $326 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 421 | N/A |
| Accounts payable and accrued liabilities | 1,155 | 587 | 151 | 845 | 655 |
| TOTAL | $3,278 | $2,679 | $2,214 | $2,878 | $2,268 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | -40 | 135 | 247 | 155 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,278 | $2,679 | $2,214 | $2,878 | $2,268 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,841 | 109,872 | 109,872 | 100,900 | 100,750 |
| Common Shares | 111 | 110 | 110 | 101 | 98 |
| Retained earnings | -8,754 | -7,716 | -7,240 | -6,344 | -4,722 |
| Other shareholders' equity | -397 | 953 | 1,087 | 1,183 | 888 |
| TOTAL | $-3,158 | $-1,917 | $-1,307 | $-2,493 | $-1,941 |
| Total Liabilities And Equity | $119 | $762 | $906 | $385 | $326 |